Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback